Literature DB >> 22198439

Sema4D as an inhibitory regulator in oligodendrocyte development.

Wataru Yamaguchi1, Rie Tamai, Miho Kageura, Tatsuo Furuyama, Shinobu Inagaki.   

Abstract

The specific functions of intrinsic regulators of OL differentiation are poorly understood. Sema4D, originally found as a negative regulator of axon guidance, is mainly expressed by oligodendrocytes in the postnatal brain, and our previous study revealed that the lack of Sema4D induced an increase in the number of oligodendrocytes in the cerebral cortex, suggesting that Sema4D may function as an intrinsic regulator of oligodendrocyte development. In this study, we assessed the effects of Sema4D deficiency and of the exogenous addition of Sema4D on oligodendrocyte differentiation. Sema4D deficiency induced an increase in the number of oligodendrocytes in the cerebral cortex at postnatal day 14 and later, without increase in the number of oligodendrocyte progenitor cells. This increase was also observed in cultured oligodendrocytes obtained from Sema4D-deficient mice. Then we investigated whether Sema4D deficiency can increase the proliferation of the progenitor cells or influence the apoptosis. Apoptotic oligodendrocytes were markedly reduced in number in the developing cerebral cortex and in cultured oligodendrocytes obtained from Sema4D-deficient mice, although no significant change was found in proliferation of oligodendrocyte progenitor cells. Exogenous addition of Sema4D prevented the oligodendrocytes from this reduction of apoptosis, and further enhanced apoptosis in oligodendrocytes. Thus, Sema4D may act as an intrinsic inhibitory regulator of oligodendrocyte differentiation by promoting apoptosis. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198439     DOI: 10.1016/j.mcn.2011.12.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  13 in total

1.  [New therapeutic strategies for remyelination in multiple sclerosis].

Authors:  D Kremer; H-P Hartung; M Stangel; P Küry
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 2.  Semaphorins and their Signaling Mechanisms.

Authors:  Laura Taylor Alto; Jonathan R Terman
Journal:  Methods Mol Biol       Date:  2017

Review 3.  The environment rules: spatiotemporal regulation of oligodendrocyte differentiation.

Authors:  Sonia R Mayoral; Jonah R Chan
Journal:  Curr Opin Neurobiol       Date:  2016-04-26       Impact factor: 6.627

Review 4.  Transmembrane semaphorins, forward and reverse signaling: have a look both ways.

Authors:  Chiara Battistini; Luca Tamagnone
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 5.  Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Authors:  Sreeharsha Gurrapu; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2016-06-13       Impact factor: 3.405

Review 6.  Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration.

Authors:  Feng Mei; S Y Christin Chong; Jonah R Chan
Journal:  Neurosci Bull       Date:  2013-03-20       Impact factor: 5.203

Review 7.  Remyelination Therapy in Multiple Sclerosis.

Authors:  Danielle E Harlow; Justin M Honce; Augusto A Miravalle
Journal:  Front Neurol       Date:  2015-12-10       Impact factor: 4.003

8.  Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice.

Authors:  Takuji Ito; Tao Bai; Tetsuji Tanaka; Kenji Yoshida; Takashi Ueyama; Masayasu Miyajima; Takayuki Negishi; Takahiko Kawasaki; Hyota Takamatsu; Hitoshi Kikutani; Atsushi Kumanogoh; Kazunori Yukawa
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodeling.

Authors:  Takuji Ito; Tao Bai; Tetsuji Tanaka; Kenji Yoshida; Takashi Ueyama; Masayasu Miyajima; Takayuki Negishi; Takahiko Kawasaki; Hyota Takamatsu; Hitoshi Kikutani; Atsushi Kumanogoh; Kazunori Yukawa
Journal:  Mol Med Rep       Date:  2014-10-27       Impact factor: 2.952

Review 10.  Secondary White Matter Injury and Therapeutic Targets After Subarachnoid Hemorrhage.

Authors:  Xufang Ru; Ling Gao; Jiru Zhou; Qiang Li; Shilun Zuo; Yujie Chen; Zhi Liu; Hua Feng
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.